DUPHASTON

This brand name is authorized in Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, France, Germany, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, Nigeria, Poland, Romania, Singapore, South Africa, Tunisia, Turkey, UK.

Active ingredients

The drug DUPHASTON contains one active pharmaceutical ingredient (API):

1	Dehydroprogesterone UNII 90I02KLE8K - DYDROGESTERONE
	Dydrogesterone is an orally-active progestogen having an activity comparable to parenterally administered progesterone.
	Read more about Dehydroprogesterone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DUPHASTON Film-coated tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03DB01	Dydrogesterone	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03D Progestogens → G03DB Pregnadien derivatives
Discover more medicines within G03DB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	500214100033217, 500214100033307
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00542072, 00542089, 01682786, 03904587, 16596727, 16838544
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	29426-10-10
EE	Ravimiamet	1054752, 1529344
FR	Base de données publique des médicaments	64866204
GB	Medicines & Healthcare Products Regulatory Agency	39417
HK	Department of Health Drug Office	32067
HR	Agencija za lijekove i medicinske proizvode	HR-H-511623868
IE	Health Products Regulatory Authority	22818
IL	מִשְׂרַד הַבְּרִיאוּת	8190
JP	医薬品医療機器総合機構	2478003F1031
LT	Valstybinė vaistų kontrolės tarnyba	1006243, 1051319, 1054622, 1067933, 1070168, 1075480, 1078899
MT	Medicines Authority	MA1507/00601, PI1438/03501A, PI908/03301A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	110M2006
NG	Registered Drug Product Database	04-1379
Switch country to Nigeria in order to find specific presentations of DUPHASTON
NL	Z-Index G-Standaard, PRK	906
PL	Rejestru Produktów Leczniczych	100100891, 100239637, 100254128, 100260940, 100278896, 100283466, 100290503, 100324389, 100327933, 100336524, 100339089, 100348450, 100348622, 100358448, 100393189, 100431843, 100436480, 100438779, 100440084, 100453600
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W69083001, W69083002
SG	Health Sciences Authority	11255P
TN	Direction de la Pharmacie et du Médicament	22843011
TR	İlaç ve Tıbbi Cihaz Kurumu	8699820010065
ZA	Health Products Regulatory Authority	S/21.8.2/165